What does CUSIP 29664W105 represent in this 13F holders report?

CUSIP 29664W105 is the security identifier for ESPR - Esperion Therapeutics, Inc. - COM used to aggregate holder disclosures.

How many institutions held ESPR - Esperion Therapeutics, Inc. - COM in Q2 2015?

150 institutional investors reported ESPR - Esperion Therapeutics, Inc. - COM for Q2 2015. Use the holders table for investor-level position and value details.

Esperion Therapeutics, Inc. - COM (ESPR)

CUSIP: 29664W105

Q2 2015 13F Holders as of 30 Jun 2015

Type / Class: Equity / COM
Shares outstanding: 258,506,508
Total 13F shares: 15,304,049
Share change: +2,383,293
Total reported value: $1,251,247,346
Put/Call ratio: 39%
Price per share: $81.76
Number of holders: 150
Value change: +$182,794,461
Number of buys: 112
Number of sells: 60

Quarterly Holders Quick Answers

What is CUSIP 29664W105?
CUSIP 29664W105 identifies ESPR - Esperion Therapeutics, Inc. - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2015
Previous quarter: Q1 2015

Recent filing periods for CUSIP 29664W105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ESPR - Esperion Therapeutics, Inc. - COM (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
FMR LLC	13F	Company	0.85%	2,186,332	$202,454,000	—	31 Mar 2015	13F
Visium Asset Management, LP	13F	Company	0.54%	1,403,600	$129,974,000	—	31 Mar 2015	13F
Pentwater Capital Management LP	13F	Company	0.5%	1,296,000	$120,010,000	—	31 Mar 2015	13F
GILDER GAGNON HOWE & CO LLC	13F	Company	0.31%	805,990	$74,635,000	—	31 Mar 2015	13F
WASATCH ADVISORS LP	13F	Company	0.29%	755,571	$69,966,000	—	31 Mar 2015	13F
VANGUARD GROUP INC	13F	Company	0.15%	396,320	$36,700,000	—	31 Mar 2015	13F
STATE STREET CORP	13F	Company	0.15%	392,848	$36,379,000	—	31 Mar 2015	13F
Polar Capital LLP	13F	Company	0.15%	377,053	$34,915,000	—	31 Mar 2015	13F
COLUMBUS CIRCLE INVESTORS	13F	Company	0.1%	247,195	$22,890,000	—	31 Mar 2015	13F
Granahan Investment Management, LLC	13F	Company	0.09%	232,780	$21,555,000	—	31 Mar 2015	13F
BlackRock Institutional Trust Company, N.A.	13F	Company	0.08%	205,188	$19,000,000	—	31 Mar 2015	13F
Iguana Healthcare Management, LLC	13F	Company	0.08%	200,000	$18,520,000	—	31 Mar 2015	13F
BlackRock Fund Advisors	13F	Company	0.07%	186,692	$17,288,000	—	31 Mar 2015	13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP	13F	Company	0.07%	173,336	$16,051,000	—	31 Mar 2015	13F
DEUTSCHE BANK AG\	13F	Company	0.07%	170,444	$15,781,000	—	31 Mar 2015	13F
Independence Capital Asset Partners, LLC	13F	Company	0.06%	158,480	$14,675,000	—	31 Mar 2015	13F
S.c.a. Candriam	13F	Individual	0.06%	143,000	$13,245,000	—	31 Mar 2015	13F
TWO SIGMA INVESTMENTS, LP	13F	Company	0.05%	138,983	$12,870,000	—	31 Mar 2015	13F
VIKING GLOBAL INVESTORS LP	13F	Company	0.05%	136,919	$12,679,000	—	31 Mar 2015	13F
Rhenman & Partners Asset Management AB	13F	Company	0.05%	126,926	$11,753,000	—	31 Mar 2015	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.05%	124,644	$11,542,000	—	31 Mar 2015	13F
MARSHALL WACE, LLP	13F	Company	0.04%	116,138	$10,754,000	—	31 Mar 2015	13F
CITADEL ADVISORS LLC	13F	Company	0.04%	112,937	$10,458,000	—	31 Mar 2015	13F
Invesco Ltd.	13F	Company	0.04%	112,435	$10,411,000	—	31 Mar 2015	13F
TIVERTON ASSET MANAGEMENT LLC	13F	Company	0.04%	110,100	$10,195,000	—	31 Mar 2015	13F
JPMORGAN CHASE & CO	13F	Company	0.04%	107,674	$9,970,000	—	31 Mar 2015	13F
HIGHBRIDGE CAPITAL MANAGEMENT LLC	13F	Company	0.04%	94,527	$8,754,000	—	31 Mar 2015	13F
Informed Momentum Co LLC	13F	Company	0.03%	89,335	$8,272,000	—	31 Mar 2015	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.03%	87,709	$8,121,000	—	31 Mar 2015	13F
SCHRODER INVESTMENT MANAGEMENT GROUP	13F	Company	0.03%	81,200	$7,361,000	—	31 Mar 2015	13F
AXA S.A.	13F	Company	0.03%	78,091	$7,231,000	—	31 Mar 2015	13F
BOGLE INVESTMENT MANAGEMENT L P /DE/	13F	Company	0.03%	74,291	$6,879,000	—	31 Mar 2015	13F
Nicholas Investment Partners, LP	13F	Company	0.03%	72,909	$6,751,000	—	31 Mar 2015	13F
NORTHERN TRUST CORP	13F	Company	0.03%	71,234	$6,596,000	—	31 Mar 2015	13F
JENNISON ASSOCIATES LLC	13F	Company	0.03%	70,047	$6,486,000	—	31 Mar 2015	13F
Pier Capital, LLC	13F	Company	0.03%	69,909	$6,474,000	—	31 Mar 2015	13F
Bank of New York Mellon Corp	13F	Company	0.03%	69,406	$6,427,000	—	31 Mar 2015	13F
AQR CAPITAL MANAGEMENT LLC	13F	Company	0.03%	68,000	$6,297,000	—	31 Mar 2015	13F
Allianz Asset Management GmbH	13F	Company	0.03%	65,167	$6,034,000	—	31 Mar 2015	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.02%	58,444	$5,412,000	—	31 Mar 2015	13F
OppenheimerFunds, Inc.	13F	Company	0.02%	56,355	$5,218,000	—	31 Mar 2015	13F
EverPoint Asset Management, LLC	13F	Company	0.02%	55,000	$5,093,000	—	31 Mar 2015	13F
MORGAN STANLEY	13F	Company	0.02%	51,971	$4,813,000	—	31 Mar 2015	13F
VOYA INVESTMENT MANAGEMENT LLC	13F	Company	0.02%	49,865	$4,617,000	—	31 Mar 2015	13F
A.R.T. Advisors, LLC	13F	Company	0.02%	43,696	$4,046,000	—	31 Mar 2015	13F
CREDIT SUISSE AG/	13F	Company	0.02%	43,613	$4,039,000	—	31 Mar 2015	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.02%	40,432	$3,744,000	—	31 Mar 2015	13F
EVENTIDE ASSET MANAGEMENT, LLC	13F	Company	0.02%	39,000	$3,611,000	—	31 Mar 2015	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.01%	36,000	$3,334,000	—	31 Mar 2015	13F
Teachers Pension Plan Board Ontario	13F	Individual	0.01%	32,678	$3,026,000	—	31 Mar 2015	13F

Institutional Holders of Esperion Therapeutics, Inc. - COM (ESPR) as of Q2 2015

As of 30 Jun 2015, Esperion Therapeutics, Inc. - COM (ESPR) was held by 150 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 15,304,049 shares. The largest 10 holders included FMR LLC, Pentwater Capital Management LP, Viking Global Investors LP, GILDER GAGNON HOWE & CO LLC, Visium Asset Management, LP, VANGUARD GROUP INC, WASATCH ADVISORS INC, COLUMBUS CIRCLE INVESTORS, STATE STREET CORP, and Polar Capital LLP. This page lists 150 institutional shareholders reporting positions in this security for the Q2 2015 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2015 vs Q1 2015 Across Filers

Q1 2015 holders

139

Q2 2015 holders

150

Holder diff

Investor	Q1 2015 Shares	Q2 2015 Shares	Share Diff	Share Chg %	Q1 2015 Value $	Q2 2015 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.